On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Impact

InstitutionResearch output, impact & collaborations

Impact is a institution indexed in ScholarIQ from OpenAlex.

What is known about Impact?

ScholarIQrecord summary

Impact is a research organisation in Ottawa, CA. OpenAlex records 16,380 works and 1,177,545 citations for it. 3,858 researchers list it as their most recent affiliation.

How many works does Impact have?

ScholarIQindexed works

Impact has 16,380 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Impact have?

ScholarIQcitation count

Impact has 1,177,545 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Impact?

ScholarIQresearcher count

Impact has 3,858 researchers in the ScholarIQ index.

What is the average h-index at Impact?

ScholarIQavg h-index

Impact has an average h-index of 64.7 in OpenAlex.

What is the ROR of Impact?

ScholarIQror

The ROR for Impact is on the source record.

What is the OpenAlex record for Impact?

ScholarIQopenalex

The OpenAlex for Impact is on the source record.

Who are the most-cited researchers behind Impact?

ScholarIQtop researchers by citations
1
Gordon Guyatt · Meta-analysis and systematic reviews
2,182 works311,786 citations
2
Gina Agarwal · Chronic Disease Management Strategies
258 works97,114 citations
3
Edward J Mills · Global Maternal and Child Health
33 works86,246 citations
4
Roman Jaeschke · Meta-analysis and systematic reviews
134 works68,665 citations
5
Bram Rochwerg · Sepsis Diagnosis and Treatment
589 works45,961 citations

What are the most-cited papers on Impact?

ScholarIQmost cited works
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon Guyatt, Andrew D Oxman, Gunn Elisabeth Vist, Regina Kunz, Yngve Falck–Ytter, Pablo Alonso‐Coello, Holger J. Schünemann
BMJ. 200822,655 CitationsOPEN ACCESS
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Gordon Guyatt, Andrew D Oxman, Elie A. Akl, Regina Kunz, Gunn Elisabeth Vist, Jan Brożek, Susan L. Norris, Yngve Falck–Ytter, Paul Glasziou, Hans deBeer
Journal of Clinical Epidemiology. 201110,645 Citations
Surviving Sepsis Campaign
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flávia Ribeiro Machado, Gordon D. Rubenfeld, S. A. R. Webb, Richard Beale, Jean‐Louis Vincent, Rui P. Moreno
Critical Care Medicine. 20139,750 Citations
Grading quality of evidence and strength of recommendations
David C. Atkins, Dana Best, Peter A. Briss, Martin Eccles, Yngve Falck–Ytter, Signe Flottorp, Gordon Guyatt, Robin Harbour, Margaret Haugh, David Henry, Suzanne Hill, Roman Jaeschke, Gillian Leng, Alessandro Liberati, Nicola Magrini, James Mason, Philippa Middleton, Jacek Mrukowicz, Dianne O’Connell, Andrew D Oxman, Bob Phillips, Holger J. Schünemann, Tessa Tan-Torres Edejer, Helena Varonen, Gunn Elisabeth Vist, John W Williams, Stephanie Zaza
BMJ. 20048,508 CitationsOPEN ACCESS
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R.P. Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flávia Ribeiro Machado, Gordon D. Rubenfeld, S. A. R. Webb, Richard Beale, Jean‐Louis Vincent, Rui P. Moreno
Intensive Care Medicine. 20137,357 CitationsOPEN ACCESS

How much of the research on Impact is open access?

ScholarIQopen access share
42%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
8%
Bronze
17%
Closed
58%

Related on ScholarIQ

470M+ articles · 14-day free trial